BPG is committed to discovery and dissemination of knowledge
Featured Articles
11/13/2018 12:36:08 AM | Browse: 1479 | Download: 2587
Publication Name World Journal of Hematology
Manuscript ID 40569
Country Spain
ISSN 2218-6204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Hematology
Manuscript Type Editorial
Article Title miRNA and platelet genetic machinery
Manuscript Source Invited Manuscript
All Author List Pedro C Redondo
Funding Agency and Grant Number
Corresponding Author Pedro C Redondo, PhD, Academic Research, Professor, Department of Physiology, Institute of Molecular Pathology Biomarkers, University of Extremadura, Plaza de Caldereros, s/n., Caceres 10003, Spain. pcr@unex.es
Key Words Platelets; Thrombosis; Certain agonists; miRNA
Core Tip miRNAs have been recently identified as a mechanism for regulating protein content in several cell types including platelets. In fact, certain miRNAs have been recently associated with some platelet-related pathologies. Moreover, changes in the miRNAs expression profiles have been evidenced in platelet activated by certain agonists. So, future researches will be needed to provide more information regarding platelet miRNAs in order to be used as an alternative therapy to the nowadays antiplatelet drugs.
Publish Date 2018-11-12 08:22
Citation Redondo PC. miRNA and platelet genetic machinery. World J Hematol 2018; 7(1): 1-3
URL http://www.wjgnet.com/2218-6204/full/v7/i1/1.htm
DOI http://dx.doi.org/10.5315/wjh.v7.i1.1
Full Article (PDF) WJH-7-1.pdf
Full Article (Word) WJH-7-1.doc